Sheila Loxton shares how oral immunotherapy has significantly improved the lives of her children, Josh and Erin, who suffer from severe food allergies. After experiencing life-threatening reactions, the family sought treatment options and found success with oral immunotherapy, w…
The FDA has granted accelerated approval to Tudriqev, a new engineered viral immunotherapy for patients with treatment-resistant advanced melanoma. This therapy, used in combinati…
Recent research highlights the importance of arginine, an amino acid, in maintaining immune function. Low levels of arginine may hinder the immune system's ability to recognize an…
A recent study from UCLA published in iScience suggests that creatine, commonly known as a muscle supplement, may enhance the energy levels of immune cells involved in fighting ca…
A recent study explores the relationship between hematologic biomarkers and endocrine-related adverse events (irAEs) in lung cancer patients undergoing immunotherapy. The research…
Recent research suggests that Bifidobacterium animalis, a common probiotic found in yogurt, may enhance the immune system's ability to combat melanoma. The study, conducted using…
A recent study from UCLA suggests that creatine, commonly known as a sports supplement, may enhance the immune system's ability to combat cancer by boosting the activity of dendri…
Recent research highlights the potential of the probiotic strain Bifidobacterium animalis in enhancing the immune response against melanoma, suggesting it may improve the effectiv…
A recent study from UCLA suggests that creatine, commonly known for its use in sports supplements, may also bolster the immune system's ability to combat cancer. The research indi…
Lauren Spiezia, a breast cancer survivor, made a powerful statement by running the New York Marathon topless, proudly displaying her scars to raise awareness for the disease. Comp…
Over 50 bipartisan lawmakers are urging the Trump administration to reconsider a proposed Medicare policy, asserting it could hinder innovation in cancer treatment and patient acc…
BioNTech SE's stock fell by 8% after the company halted its Phase 2 colorectal cancer vaccine trial due to futility. This decision has also affected other mRNA vaccine stocks, inc…